Patents by Inventor Miriam Anver

Miriam Anver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same
    Patent number: 8957188
    Abstract: Monoclonal antibodies to carbohydrate antigens containing a terminal GalNAc?1-3Gal are provided. The antibodies of the present invention are found to specifically recognize GalNAc?1-3Gal with little cross-reactivity to other structurally similar antigens such as GalNAc?1-6Gal, blood group A, Forssman antigen and the Tn antigen on both solution assays and human tissue. Compositions comprising the monoclonal antibodies, as well as methods of diagnosis, treatment and prognostication are also provided.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: February 17, 2015
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jeffrey Gildersleeve, Zhitao Li, Qian Li, Miriam Anver, Donna O. Butcher
  • ANTIBODIES THAT BIND GalNAc1-3Gal, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
    Publication number: 20100254898
    Abstract: Monoclonal antibodies to carbohydrate antigens containing a terminal GalNAc?1-3Gal are provided. The antibodies of the present invention are found to specifically recognize GalNAc?1-3Gal with little cross-reactivity to other structurally similar antigens such as GalNAc?1-6Gal, blood group A, Forssman antigen and the Tn antigen on both solution assays and human tissue. Compositions comprising the monoclonal antibodies, as well as methods of diagnosis, treatment and prognostication are also provided.
    Type: Application
    Filed: April 1, 2010
    Publication date: October 7, 2010
    Applicants: Human Services
    Inventors: Jeffrey Gildersleeve, Zhitao Li, Qian Li, Miriam Anver, Donna O. Butcher